UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications

Proceedings of the National Academy of Sciences - PNAS, 2021-04, Vol.118 (16), p.1

2021

Volltextzugriff (PDF)

Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivo

mAbs, 2020-01, Vol.12 (1), p.1836713-1836713

2020

Volltextzugriff (PDF)

An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties

Pharmaceutics, 2023-01, Vol.15 (2), p.377

2023

Volltextzugriff (PDF)

Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody

Journal for immunotherapy of cancer, 2022-09, Vol.10 (9), p.e005282

2022

Volltextzugriff (PDF)

Intratumoral administration of daromun in non‐melanoma skin cancer: Preliminary results from a phase 2 non‐randomized controlled trial

Journal of the European Academy of Dermatology and Venereology, 2024-06

2024

Volltextzugriff (PDF)

Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors

Clinical cancer research, 2022-12, Vol.28 (24), p.5440-5454

2022

Volltextzugriff (PDF)

Selection of a PD‐1 blocking antibody from a novel fully human phage display library

Protein science, 2022-12, Vol.31 (12), p.e4486-n/a

2022

Volltextzugriff (PDF)

Abstract LB535: A novel IL12-based immunocytokine targeting fibroblast activation protein (FAP) for the treatment of cancer

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.LB535-LB535

2022

Volltextzugriff (PDF)

Selective tumor targeting enabled by picomolar fibroblast activation protein inhibitors isolated from a DNA-encoded affinity maturation library

Chem, 2023-02, Vol.9 (2), p.411-429

2023

Volltextzugriff (PDF)

Abstract LB522: Fibroblast activation protein triggers the release of drug payload from non-internalizing small molecule-drug conjugates in solid tumors

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.LB522-LB522

2022

Volltextzugriff (PDF)

1093 A novel IL12-based immunocytokine targeting fibroblast activation protein (FAP) for the treatment of cancer

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A1136-A1136

2022

Volltextzugriff (PDF)

Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivo

mAbs, 2020, Vol.12 (1)

2020

Volltextzugriff (PDF)

Chaperones ameliorate beta cell dysfunction associated with human islet amyloid polypeptide overexpression

PloS one, 2014-07, Vol.9 (7), p.e101797

2014

Volltextzugriff (PDF)

Ecological markers to monitor migratory bird populations: Integrating citizen science and transboundary management for conservation purposes

Journal of environmental management, 2020-02, Vol.255, p.109875-109875, Article 109875

2020

Volltextzugriff (PDF)

Effectiveness of behaviour change techniques on lifestyle interventions of patients with a high risk of developing cardiovascular disease. Using a qualitative approach

Health & social care in the community, 2020-05, Vol.28 (3), p.998-1009

2020

Volltextzugriff (PDF)

Validation of Electronic Health Record Phenotyping of Bipolar Disorder Cases and Controls

The American journal of psychiatry, 2015-04, Vol.172 (4), p.363-372

2015

Volltextzugriff (PDF)

SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

European heart journal, 2023-07, Vol.44 (28), p.2544-2556

2023

Volltextzugriff (PDF)

A vision for safer food contact materials: Public health concerns as drivers for improved testing

Environment international, 2023-10, Vol.180, p.108161-108161, Article 108161

2023

Volltextzugriff (PDF)

Comparison of peripheral blood markers in predicting the occurrence of immune-related adverse events in patients with metastatic genitourinary cancer treated with cabozantinib + nivolumab +/- ipilimumab

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e16506-e16506

2023

Volltextzugriff (PDF)

580: Maternal morbidity after early preterm delivery (23-28 weeks)

American journal of obstetrics and gynecology, 2019-01, Vol.220 (1), p.S385-S386

2019

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

SpracheFranzösisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Englisch
(49)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications

Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivo

An Engineered IFNγ-Antibody Fusion Protein with Improved Tumor-Homing Properties

Generation and in vivo validation of an IL-12 fusion protein based on a novel anti-human FAP monoclonal antibody

Intratumoral administration of daromun in non‐melanoma skin cancer: Preliminary results from a phase 2 non‐randomized controlled trial

Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors

Selection of a PD‐1 blocking antibody from a novel fully human phage display library

Abstract LB535: A novel IL12-based immunocytokine targeting fibroblast activation protein (FAP) for the treatment of cancer

Selective tumor targeting enabled by picomolar fibroblast activation protein inhibitors isolated from a DNA-encoded affinity maturation library

Abstract LB522: Fibroblast activation protein triggers the release of drug payload from non-internalizing small molecule-drug conjugates in solid tumors

1093 A novel IL12-based immunocytokine targeting fibroblast activation protein (FAP) for the treatment of cancer

Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivo

Chaperones ameliorate beta cell dysfunction associated with human islet amyloid polypeptide overexpression

Ecological markers to monitor migratory bird populations: Integrating citizen science and transboundary management for conservation purposes

Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

Effectiveness of behaviour change techniques on lifestyle interventions of patients with a high risk of developing cardiovascular disease. Using a qualitative approach

Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial

Validation of Electronic Health Record Phenotyping of Bipolar Disorder Cases and Controls

SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

A vision for safer food contact materials: Public health concerns as drivers for improved testing

Comparison of peripheral blood markers in predicting the occurrence of immune-related adverse events in patients with metastatic genitourinary cancer treated with cabozantinib + nivolumab +/- ipilimumab

Tree mortality submodels drive simulated long‐term forest dynamics: assessing 15 models from the stand to global scale

580: Maternal morbidity after early preterm delivery (23-28 weeks)

Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy

Study protocol for a pragmatic cluster randomized controlled trial to improve dietary diversity and physical fitness among older people who live at home (the “ALAPAGE study”)

Aktive Filter

Suchergebnisse filtern